Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andy Gaya

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Clinical Evidence|September 16, 2006
Breast cancer (metastatic)Justin Stebbing, Jeremy Crane, Andy Gaya
Cureus|February 3, 2016
Tumor Biology: Is It Time to Redefine Unresectability? An Extraordinary Case of Gastroesophageal Junctional AdenocarcinomaAndy Gaya, Alex Giakoustidis, Mark Winslet, et al.
Cureus|July 17, 2015
The Concept of Hormesis in Cancer Therapy - Is Less More?Andy Gaya, Charles A Akle, Satvinder Mudan, et al.
Cureus|February 13, 2016
Extended Survival after Complete Pathological Response in Metastatic Pancreatic Ductal Adenocarcinoma Following Induction Chemotherapy, Chemoradiotherapy, and a Novel Immunotherapy Agent, IMM-101Mafalda Costa Neves, Alex Giakoustidis, Gordon Stamp, et al.
Gastrointestinal Tumors|March 30, 2018
Waiting Time following Neoadjuvant Chemoradiotherapy for Rectal Cancer: Does It Really MatterAris Plastiras, Michail Sideris, Andy Gaya, et al.
Clinical and Translational Radiation Oncology|December 24, 2025
Daily adaptive MR-guided stereotactic ablative re-irradiation (re-SABR) in oligometastatic liver disease: A single-institution retrospective analysisElena Moreno-Olmedo, Dan Murray, Ben George, et al.
Advances in Radiation Oncology|November 10, 2025
Safety and Efficacy of Stereotactic Magnetic Resonance-Guided Adaptive Radiation Therapy (SMART) for Ultracentral Metastases in Non-Small Cell Lung CancerElena Moreno-Olmedo, Ben George, Kasia Owczarczyk, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Clinical Evidence|September 16, 2006
Breast cancer (metastatic)Justin Stebbing, Jeremy Crane, Andy Gaya
Cureus|February 3, 2016
Tumor Biology: Is It Time to Redefine Unresectability? An Extraordinary Case of Gastroesophageal Junctional AdenocarcinomaAndy Gaya, Alex Giakoustidis, Mark Winslet, et al.
Cureus|July 17, 2015
The Concept of Hormesis in Cancer Therapy - Is Less More?Andy Gaya, Charles A Akle, Satvinder Mudan, et al.
Cureus|February 13, 2016
Extended Survival after Complete Pathological Response in Metastatic Pancreatic Ductal Adenocarcinoma Following Induction Chemotherapy, Chemoradiotherapy, and a Novel Immunotherapy Agent, IMM-101Mafalda Costa Neves, Alex Giakoustidis, Gordon Stamp, et al.
Gastrointestinal Tumors|March 30, 2018
Waiting Time following Neoadjuvant Chemoradiotherapy for Rectal Cancer: Does It Really MatterAris Plastiras, Michail Sideris, Andy Gaya, et al.
Clinical and Translational Radiation Oncology|December 24, 2025
Daily adaptive MR-guided stereotactic ablative re-irradiation (re-SABR) in oligometastatic liver disease: A single-institution retrospective analysisElena Moreno-Olmedo, Dan Murray, Ben George, et al.
Advances in Radiation Oncology|November 10, 2025
Safety and Efficacy of Stereotactic Magnetic Resonance-Guided Adaptive Radiation Therapy (SMART) for Ultracentral Metastases in Non-Small Cell Lung CancerElena Moreno-Olmedo, Ben George, Kasia Owczarczyk, et al.
Pageof 1